Peter Wehrly - Rewalk Robotics Independent Director
| RWLKDelisted Stock | USD 1.05 0.04 3.96% |
Director
Mr. Peter L. Wehrly serves as Independent Director of the Company. Mr. Wehrly has served on our Board since April 5, 2016. Mr. Wehrly previously served in multiple senior roles at Covidien plc, including Group President of Developed Markets and Group President of Respiratory Monitoring Solutions and Vascular Therapies from 2009 until 2015, during which Covidien was a public company listed on the New York Stock Exchange. Prior to joining Covidien, Mr. Wehrly served as President and Chief Executive Officer at Medingo Ltd., an Israelbased company, from 2008 to 2009. From 2000 to 2008 he held senior executivelevel roles at Medtronic Spinal and Biologics in Memphis, Tennessee, where he oversaw the global market expansion of Medtronics core spinal fusion therapies, minimal access technologies, motionsparing devices and biologic technologies. Prior to that, Mr. Wehrly spent 17 years at DePuy, a division of Johnson Johnson, and most recently served as DePuys Sports Medicine Division President from 1997 to 2000. Throughout his career at various companies, Mr. Wehrly headed regional strategies to gain regulatory approval and reimbursement for new technologies in Europe, Japan, Australia, New Zealand, the United States and Canada. In addition, since 2012 Mr. Wehrly was a director of Non Linear Technologies Ltd since 2016.
| Age | 56 |
| Tenure | 8 years |
| Phone | 972 4 959 0123 |
| Web | https://www.rewalk.com |
Rewalk Robotics Management Efficiency
The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Rewalk Robotics until it has trouble settling it off, either with new capital or with free cash flow. So, Rewalk Robotics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rewalk Robotics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rewalk to invest in growth at high rates of return. When we think about Rewalk Robotics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Samuel Navarro | STRATA Skin Sciences | ||
| Shawn McCormick | SurModics | 53 | |
| James Coyne | STRATA Skin Sciences | N/A | |
| Bret Hankey | Bone Biologics Corp | 39 | |
| John Benson | SurModics | 69 | |
| Gavriel Magen | BrainsWay | 54 | |
| Yiftach Roth | BrainsWay | 52 | |
| Yosef Shalom | BrainsWay | 61 | |
| David Dantzker | SurModics | 74 | |
| Susan Knight | SurModics | 63 | |
| Benjamin Wu | Bone Biologics Corp | 53 | |
| Lisa Heine | SurModics | 54 | |
| Yuval Lavi | BrainsWay | 54 | |
| Chia Soo | Bone Biologics Corp | 47 | |
| Uri Elmaliach | BrainsWay | 65 | |
| John Booth | Bone Biologics Corp | 60 | |
| Ronald Kalich | SurModics | 70 | |
| Michael Ferguson | NanoVibronix | 42 | |
| Abraham Zangen | BrainsWay | N/A | |
| LuAnn Via | STRATA Skin Sciences | 61 | |
| Kathryn Swintek | STRATA Skin Sciences | 62 | |
Management Performance
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 |
Rewalk Robotics Leadership Team
Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, CEO Director | ||
| Jeff Dykan, Independent Chairman of the Board | ||
| Jay Kalish, Independent Director | ||
| John Hamilton, Vice President - Regulatory and Clinical | ||
| Miri Pariente, Global Director - Quality | ||
| Yohanan Engelhardt, Director | ||
| Charles Remsberg, Chief Officer | ||
| Glenn Muir, Independent Director | ||
| Wayne Weisman, Independent Director | ||
| Kevin Hershberger, CFO | ||
| Michael Lawless, Chief Officer | ||
| Deborah DiSanzo, Director | ||
| Lawrence Jasinski, CEO, Director | ||
| Ofir Koren, VP of RandD | ||
| Ning Cong, Independent Director | ||
| Ami Kraft, Ex CEO | ||
| Asaf Shinar, Independent Director | ||
| Judy Kula, Human Service | ||
| John Poduska, Independent Director Nominee | ||
| Ori Gon, CFO | ||
| Ori Schellas, Director of Operations | ||
| Aryeh Dan, Director | ||
| David Hexner, VP RD | ||
| Chunlin Han, Director | ||
| Kathleen ODonnell, Vice Development | ||
| Larry Jasinski, CEO, Director | ||
| Jodi Gricci, VP of Global Marketing | ||
| Hadar Ron, Independent Director | ||
| Peter Wehrly, Independent Director | ||
| Yasushi Ichiki, Director | ||
| Jeannine Lynch, Vice Strategy |
Rewalk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rewalk Robotics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rewalk Robotics' short interest history, or implied volatility extrapolated from Rewalk Robotics options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |